Bill Ackman's Big Pharma Trade: The Drama Doesn't Stop
Article By:
TalkMarkets DailyTalk
Read
Friday, October 24, 2014 1:31 PM EDT
If you're following Valeant's proposed takeover (or merger) of Allergan and the lawsuit by Allergan against Valeant and notorious hedge fund manager William Ackman for insider trading, this is a must-read article.
Tekmira And J&J’s Ebola Drugs Advance Towards Deployment In West Africa
Article By:
PropThink
Read
Wednesday, October 22, 2014 9:07 AM EDT
Tekmira Pharmaceuticals (TKMR) and European drug developer Bavarian Nordic (BAVA.CO) are receiving significant attention in early trading on Wednesday morning with announcements that their two distinct approaches to Ebola, a therapeutic and vaccine respectively, are advancing.
American Realty Capital Healthcare - Buy Signals
Article By:
Jim Van Meerten
Read
Wednesday, October 22, 2014 4:10 AM EDT
I added American Realty Capital Healthcare to Van Meerten New High portfolio for positive price momentum.
In this article: HCT
Inovio Pharmaceuticals: Partnerships Keep Rolling In
Article By:
Terry Chrisomalis
Read
Tuesday, October 21, 2014 1:32 PM EDT
Inovio Pharmaceuticals partners with MedImmune to create monoclonal antibodies against various infections.
With Latest Data, Investors Again Compare Synergy To The Billion-Dollar Ironwood Pharma
Northwest Biotherapeutics: A Variety Of Possibilities With The Future Of Immunotherapy Treatments
Article By:
Terry Chrisomalis
Read
Tuesday, October 21, 2014 10:18 AM EDT
Northwest Biotherapeutic's recent news suggests a great buying opportunity.
In this article: NWBO
AbbVie: Staying Bullish As The Company Hikes Its Dividend 16.7%
Article By:
Matt Schilling
Read
Tuesday, October 21, 2014 3:04 AM EDT
As AbbVie hikes its quarterly dividend, I wanted to take a closer look at the company and note several reasons as to why I'm staying bullish on the company's stock.
In this article: ABBV
NewLink Genetics Scores Big Partnership Deal With Roche
Article By:
Terry Chrisomalis
Read
Monday, October 20, 2014 10:10 AM EDT
NewLink Genetics to co-develop cancer drug with Roche. Great news for NewLink.
Omega Healthcare: Staying Bullish As The Company Hikes Its Dividend
Article By:
Matt Schilling
Read
Saturday, October 18, 2014 11:42 PM EDT
In the wake of its latest dividend-related news, I wanted to take a brief look at Omega Healthcare Partners and note the impact I believe both its latest dividend hike and upcoming earnings will have on its share price.
In this article: OHI
Dividend Investing: How To Profit From America's Expanding Waistlines
Article By:
Keith Park
Read
Saturday, October 18, 2014 6:19 PM EDT
In the U.S. alone, the weight loss industry is worth more than $61 billion in annual sales. As dividend income investors. we are mostly interested in the companies in this sector that can pay us sustainable and increasing dividends year in and year out. Here's a look at a few...
Dividend Aristocrats In Focus Part 20 Of 54: Cardinal Health
Article By:
SureDividend
Read
Thursday, October 16, 2014 7:24 AM EDT
In part 20 of my 54 part series on Dividend Aristocrats, I take a closer look at the operations of Cardinal Health. In this article, you will see the company's (very strong) competitive advantage, growth prospects, and relative valuation.
The Ebola Outbreak: A Black Swan
Article By:
Acting-Man
Read
Wednesday, October 15, 2014 8:43 PM EDT
Up until now, outbreaks were quickly contained by their high mortality. The current epidemic is 20 times larger than the largest previously recorded.
Tekmira Reports Early Results On Hepatitis B Drug
Article By:
Terry Chrisomalis
Read
Wednesday, October 15, 2014 4:52 PM EDT
Tekmira reports pre-clinical results on Hepatitis B drug